When did Beam Therapeutics go public?
Beam Therapeutics officially completed its initial public offering and began trading its shares on the Nasdaq Global Select Market under the ticker symbol BEAM on February 6, 2020. The biotechnology enterprise raised substantial capital from its public market debut to advance its pioneering precision genetic medicines platform, utilizing base-editing technologies designed to develop revolutionary therapeutic treatments for patients suffering from severe genetic diseases.
Related FAQs
Stevanato Group S.p.A.
As of July 26, 2026, the estimated net worth of Steven Roth is at least $422 million, primarily based on his substantial insider holdings in Vornado Realty Trust and other real estate entities.
CIR S.p.A. (Compagnie Industriali Riunite) shares trade on Euronext Milan under ticker CIRI at approximately €0.719 per share.
Tod's S.p.A.
Stevanato Group S.p.A. trades on the New York Stock Exchange under the ticker symbol STVN at a market price of approximately $19.85 per share.
Tod's S.p.A.
Stevanato Group SpA, trading under the ticker symbol STVN, is frequently viewed by equity analysts as a compelling purchase, supported by strong global demand for specialized containment and delivery systems for the biopharmaceutical industry.
STVN represents the stock ticker symbol or corporate shorthand for various emerging biotechnology or pharmaceutical entities—most notably specialized clinical-stage therapeutic firms focusing on novel treatments for genetic, metabolic, or oncological...
Stevanato Group S.p.A.
The GEO Group, Inc.